Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 2Central Nervous System Neoplasms 2Oligodendroglioma 1Gliosarcoma 1Cognition Disorders 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 8Radiotherapy 6Procarbazine 4Radiation 3Lomustine 3Carmustine 3Dihematoporphyrin Ether 2sargramostim 1rindopepimut 1depatuxizumab mafodotin 1Vincristine 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1Photons 1O(6)-benzylguanine 1Neoadjuvant Therapy 1Methylphenidate 1Magnetic Resonance Spectroscopy 1Leflunomide 1Isotretinoin 1Immunoglobulin G 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fentanyl 1Donepezil 1Disulfides 1DNA Methylation 1Chemotherapy, Adjuvant 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Gliosarcoma × DNA Methylation × Clear all
NCT00482677 2023-08-22

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

Canadian Cancer Trials Group

Phase 3 Completed
562 enrolled 11 charts
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡